Irish Pharmaceutical Industry Outlook 2021/22

Following our UK pharma sector report, now it’s time to look at the Irish market. Please note that the full Irish pharmaceutical industry outlook is available to subscribers to the MyProtel database.

A majority of new projects over €100m & mainly in primary production

The outlook going forward is positive, though there will be a period of dealing with the existing bottleneck of large scale investment for the next 18-24 months. Right now, MyProtel contains:

• 140 projects with a combined value of €8.2 billion
• 45% of projects report on new production facilities
• 37% are about production capacity expansion plans

Here are some of the main players:

Irish Pharmaceutical Industry Outlook – the full report

Our research team has compiled the full Irish pharma and labs sector outlook packed with insights on the trends and projects to look out for. Access to this report and all the projects it refers to is reserved to our pharma & labs subscribers.

To discuss our subscription options, book a call with one of our team.